TGTX
NASDAQStockTG Therapeutics, Inc.
$26.96-1.09 (-3.89%)
52-Week Range
$26.39
$45.51
Key Stats
Market Cap
4.3B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.86
Volume
1.2M
Avg Volume
1.9M
Performance
1M
-6.52%
3M
-14.23%
6M
-15.15%
YTD
-7.99%
1Y
-27.31%
3Y
+81.05%
5Y
-43.99%
Price Chart
ETF Exposure
TGTX is held by 118 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| KOMP | State Street SPDR S&P Kensho New Economies Composite ETF | 0.09% |
| SCDS | JPMorgan Fundamental Data Science Small Core ETF | 0.09% |
| FESM | FIDELITY ENHANCED SMALL CAP ETF | 0.08% |
| URTY | ProShares - UltraPro Russell2000 | 0.08% |
| SMLF | iShares U.S. Small-Cap Equity Factor ETF | 0.08% |
| ISCB | iShares Morningstar Small-Cap ETF | 0.07% |
| JKJ | iShares Morningstar Small-Cap ETF | 0.07% |
| BALQ | iShares Nasdaq Premium Income Active ETF | 0.07% |
| JHMH | John Hancock Multifactor Health Care ETF | 0.07% |
| FHLC | FIDELITY MSCI HEALTH CARE INDEX ETF | 0.07% |
| VHT | Vanguard Health Care ETF | 0.07% |
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | 0.06% |
| VB | Vanguard Small-Cap ETF | 0.06% |
| AFMC | First Trust Active Factor Mid Cap ETF | 0.06% |
| ESML | iShares ESG Aware MSCI USA Small-Cap ETF | 0.05% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.05% |
| VXF | Vanguard Extended Market ETF | 0.05% |
| FAD | First Trust Multi Cap Growth AlphaDEX Fund | 0.04% |
| WSML | iShares MSCI World Small-Cap ETF | 0.04% |
| CSF | VictoryShares US Discovery Enhanced Volatility Wtd ETF | 0.04% |
| RWJ | Invesco S&P SmallCap 600 Revenue ETF | 0.04% |
| SMMD | iShares Russell 2500 ETF | 0.03% |
| GTPE | Goldman Sachs MSCI World Private Equity Return Tracker ETF | 0.03% |
| AVIE | Avantis Inflation Focused Equity ETF | 0.03% |
| HDG | ProShares - Hedge Replication ETF | 0.02% |
| SPGM | State Street SPDR Portfolio MSCI Global Stock Market ETF | 0.01% |
| ONEQ | FIDELITY NASDAQ COMPOSITE INDEX ETF | 0.01% |
| IALT | iShares Systematic Alternatives Active ETF | 0.01% |
| ESGV | Vanguard ESG U.S. Stock ETF | 0.01% |
| DFUS | Dimensional - US Equity Market ETF | 0.01% |
| IWV | iShares Russell 3000 ETF | 0.01% |
| VTI | Vanguard Total Stock Market ETF | 0.01% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.01% |
| SCHB | Schwab U.S. Broad Market ETF | 0.01% |
| V3AL.L | Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.01% |
| VTHR | Vanguard Russell 3000 ETF | 0.01% |
| DFAU | Dimensional - US Core Equity Market ETF | 0.01% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.00% |
| MMTM | State Street SPDR S&P 1500 Momentum Tilt ETF | 0.00% |
| SPTM | State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF | 0.00% |
| TILT | FlexShares Morningstar U.S. Market Factor Tilt Index Fund | 0.00% |
| VT | Vanguard Total World Stock ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| AOA | iShares Core 80/20 Aggressive Allocation ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| AFTY | Pacer CSOP FTSE China A50 ETF | 0.00% |
About TGTX ETF Exposure
TG Therapeutics, Inc. (TGTX) is held by 118 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 4.3B, TGTX is a widely held institutional stock. The stock currently trades at $26.96. Investors can gain exposure to TGTX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold TGTX, sorted by portfolio weight.